Esperion Therapeutics, Inc. · NASDAQ:ESPR
Two Seas Capital LP's stake in Esperion Therapeutics, Inc. fell to 4.70% (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Two Seas Capital LP's stake in Esperion Therapeutics, Inc. fell to 4.70%, 9,749,724 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 4.70%
- Shares
- 9,749,724
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Two Seas Capital LP | 4.70% | 9,749,724 |
| Two Seas Capital GP LLC | 4.70% | 9,749,724 |
| Sina Toussi | 4.70% | 9,749,724 |
Source
Related
- Esperion Therapeutics, Inc.
- Two Seas Capital LP
- Esperion Therapeutics, Inc. shareholders
- Schedule 13G · Two Seas Capital LP · Aug 13, 2025
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026